- Published at
- by gurufocus.com
mixed
mixed
News for Actinium Pharmaceuticals, Inc. (ATNM)
- Published at
- by gurufocus.com
positivepositiveActinium Pharmaceuticals Announces Research Collaboration with Memorial Sloan Kettering to Support Further Clinical Expansion of Actimab-A's Backbone Therapy Strategy
PR NewswireNEW YORK, March 20, 2025 NEW YORK, March 20, 2025 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company)- Published at
- by gurufocus.com
mixedmixedActinium Pharmaceuticals Announces Clinical Trial Program in Solid Tumors Combining Actimab-A with PD-1 Checkpoint Inhibitors KEYTRUDA® and OPDIVO®
PR NewswireNEW YORK, March 18, 2025 - Trials are designed to demonstrate whether the addition of Actimab-A to either KEYTRUDA® or OPDIVO® can resul- Published at
- by gurufocus.com
positivepositiveActinium Pharmaceuticals Announces Publication of Actimab-A + CLAG-M Trial Results in Patients with Relapsed or Refractory Acute Myeloid Leukemia in the Peer-Reviewed Journal Leukemia
PR NewswireNEW YORK, March 17, 2025 - Median Overall Survival of 18.4 months with Actimab-A + CLAG-M in patients with relapsed or refractory AML who- Published at
- by gurufocus.com
positivepositiveActinium Pharmaceuticals to Participate at the 37th Annual Roth Conference
PR NewswireNEW YORK, March 12, 2025 NEW YORK, March 12, 2025 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company)- Published at
- by rttnews.com
negativenegativeActinium Pharma Q3 Loss Narrows
Actinium Pharmaceuticals Inc. (ATNM) Monday announced a narrower loss for the third quarter. The September quarter loss was $11.6 million, compared to $13.3 million a year ago.- Published at
- by gurufocus.com
neutralneutralActinium Pharmaceuticals Highlights Antibody Radiation Conjugate Program Developments and Reports Financial Results for the Third Quarter 2024
PR NewswireNEW YORK, Nov. 18, 2024 - Aligned with FDA on operationally seamless Phase 2/3 trial for Actimab-A + CLAG-M in relapsed/refractory acute myeloi- Published at
- by globenewswire.com
mixedmixedRadiopharmaceuticals Market Size Projected to Soar to USD 16.6 Billion by 2032 with 10.4% CAGR – SNS Insider
According to Research by SNS Insider, The Radiopharmaceuticals Market growth is driven by advancements in nuclear medicine, personalized treatments, and...- Published at
- by rttnews.com
mixedmixedWeekly Review: ANTX Downsizes, ALDX Aces Dry Eye Disease Trial, FDA Oks 1st Epinephrine Nasal Spray
The week saw FDA reprimanding a pharma giant for making false and misleading claims about its non-small cell lung cancer drug and a developer of MDMA therapy for PTSD facing a major setback.- Published at
- by benzinga.com
mixedmixedWhy Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket - Palantir Technologies (NYSE:PLTR)
Shares of Palantir Technologies Inc PLTR rose sharply in today's pre-market trading after the company reported better-than-expected second-quarter results. Pal...- Published at
- by benzinga.com
positivepositiveS&P 500 Down Over 100 Points; Actinium Pharmaceuticals Shares Plunge - Concord Medical Services (NYSE:CCM), Actinium Pharma (AMEX:ATNM)
U.S. stocks traded lower toward the end of trading, with the S&P 500 dipping more than 100 points on Monday. The Dow traded down 2.3% to 38,852.44 while the NA...- Published at
- by benzinga.com
positivepositive- Published at
- by investorideas.com
mixedmixedTreatment of Blood Cancers - Stocks to watch (NYSE AMERICAN: ATNM) (NASDAQ: KURA), (NASDAQ: SYRS), (NASDAQ: SLS)
June 18, 2024 (Investorideas.com Newswire) Investorideas.com, a go-to investing platform covering biotech and medical technology stocks releases the second of a...- Published at
- by investorideas.com
mixedmixedBiopharma Stocks (NYSE American: ATNM) (NASDAQ: BPTH) (NASDAQ: STTK) (NASDAQ: MBRX) Quest for Solutions for Acute Myeloid Leukemia (AML)
June 17, 2024 (Investorideas.com Newswire) Investorideas.com, a go-to investing platform releases the first of a two-part series looking at developments for the...- Published at
- by investing.com
mixedmixed- Published at
- by rttnews.com
mixedmixedPre-market Movers: ARBE, SGML, ATNM, BTCS, OKYO…
The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.05 A.M. ET)..- Published at
- by benzinga.com
mixedmixedDollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday - Agora (NASDAQ:API), AGBA Acq (NASDAQ:AGBA)
U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session.- Published at
- by etfdailynews.com
mixedmixedInvestment Analysts’ Downgrades for June 8th (ATHX, ATNM, AVO, AVPT, BLZE, BNTC, BOWL, BSIG, CABA, CCNE)
Read Investment Analysts’ Downgrades for June 8th (ATHX, ATNM, AVO, AVPT, BLZE, BNTC, BOWL, BSIG, CABA, CCNE) at ETF Daily News- Published at
- by etfdailynews.com
mixedmixed- Published at
- by etfdailynews.com
mixedmixedInvestment Analysts’ Updated EPS Estimates for May 30th (AMPS, ARCO, ASHTY, ASML, ASTL, ATNM, AUGX, AXTI, BBAI, BBD)
Read Investment Analysts’ Updated EPS Estimates for May 30th (AMPS, ARCO, ASHTY, ASML, ASTL, ATNM, AUGX, AXTI, BBAI, BBD) at ETF Daily News